Telix Pharmaceuticals Ltd has released a press release.
Appendix 4C - September 2019 quarter
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Telix to Acquire European Production Facility
- FDA Pre-NDA Meeting Outcomes - TLX591-CDx illumet
- Appendix 4D and Financial Report for half-year to 30 June 19
- First Australian Patient Dosed in ZIRCON Phase III Trial
- Telix Pharmaceuticals announces results of successful SPP
Later from Telix Pharmaceuticals
- Telix and AusHealth Partner for Lung, Ovarian Cancer
- Telix and ATONCO Partner for Bladder Cancer
- Telix and Vic Cancer Centre receive Cancer Australia grant
- Zircon P3 IND submitted to US FDA
- NDA Clinical Briefing Package Submitted to the US FDA
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals